{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:34:04Z","timestamp":1757619244904,"version":"3.44.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01274-0","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T08:38:26Z","timestamp":1752914306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France"],"prefix":"10.1186","volume":"22","author":[{"given":"Martin","family":"Bastien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Mezaache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Donadille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00e9lia Briand","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00ebla","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perrine","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1274_CR1","unstructured":"Obradovic I, Protais C, Le N\u00e9zet O. Cinquante ans de r\u00e9ponse p\u00e9nale \u00e0 l\u2019usage de stup\u00e9fiants (1970\u20132020)| OFDT. 2021."},{"key":"1274_CR2","volume-title":"Low-THC cannabis products in Europe","author":"EMCDDA","year":"2020","unstructured":"EMCDDA. Low-THC cannabis products in Europe. Luxembourg: Publications Office of the European Union; 2020."},{"key":"1274_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/dta.220","volume":"3","author":"C Cole","year":"2011","unstructured":"Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3:89\u201396.","journal-title":"Drug Test Anal"},{"key":"1274_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","volume":"147","author":"L Hondebrink","year":"2015","unstructured":"Hondebrink L, Nugteren-van Lonkhuyzen JJ, Van Der Gouwe D, Brunt TM. Monitoring new psychoactive substances (NPS) in the netherlands: data from the drug market and the poisons information centre. Drug Alcohol Depend. 2015;147:109\u201315.","journal-title":"Drug Alcohol Depend"},{"key":"1274_CR5","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/dta.3220","volume":"14","author":"MC Monti","year":"2022","unstructured":"Monti MC, Zeugin J, Koch K, Milenkovic N, Scheurer E, Mercer-Chalmers-Bender K. Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: results from drug checking services. Drug Test Anal. 2022;14:1026\u201339.","journal-title":"Drug Test Anal"},{"key":"1274_CR6","doi-asserted-by":"publisher","first-page":"103493","DOI":"10.1016\/j.drugpo.2021.103493","volume":"100","author":"PE Oomen","year":"2022","unstructured":"Oomen PE, Schori D, T\u00f6gel-Lins K, et al. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Int J Drug Policy. 2022;100:103493.","journal-title":"Int J Drug Policy"},{"key":"1274_CR7","unstructured":"Brunt T. Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges. European Monitoring Centre for Drugs and Drug Addiction; 2017."},{"key":"1274_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, Scheim AI. Drug checking services for people who use drugs: a systematic review. Addict Abingdon Engl. 2022;117:532\u201344.","journal-title":"Addict Abingdon Engl"},{"key":"1274_CR9","doi-asserted-by":"publisher","first-page":"103972","DOI":"10.1016\/j.drugpo.2023.103972","volume":"114","author":"R Magnolini","year":"2023","unstructured":"Magnolini R, Schneider M, Schori D, Trachsel D, Bruggmann P. Substances from unregulated drug markets\u2013 A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland). Int J Drug Policy. 2023;114:103972.","journal-title":"Int J Drug Policy"},{"key":"1274_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000507049","volume":"27","author":"F Betzler","year":"2021","unstructured":"Betzler F, Helbig J, Viohl L, Ernst F, Roediger L, Gutwinski S, Str\u00f6hle A, K\u00f6hler S. Drug checking and its potential impact on substance use. Eur Addict Res. 2021;27:25\u201332.","journal-title":"Eur Addict Res"},{"key":"1274_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0205-7","volume":"15","author":"N Day","year":"2018","unstructured":"Day N, Criss J, Griffiths B, Gujral SK, John-Leader F, Johnston J, Pit S. Music festival attendees\u2019 illicit drug use, knowledge and practices regarding drug content and purity: a cross-sectional survey. Harm Reduct J. 2018;15:1.","journal-title":"Harm Reduct J"},{"key":"1274_CR12","doi-asserted-by":"crossref","unstructured":"Ivers J-H, Killeen N, Keenan E. (2021) Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers. Ir J Med Sci 1\u201310.","DOI":"10.1007\/s11845-021-02765-2"},{"key":"1274_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.drugpo.2019.07.007","volume":"73","author":"H Valente","year":"2019","unstructured":"Valente H, Martins D, Carvalho H, Pires CV, Carvalho MC, Pinto M, Barratt MJ. Evaluation of a drug checking service at a large scale electronic music festival in Portugal. Int J Drug Policy. 2019;73:88\u201395.","journal-title":"Int J Drug Policy"},{"key":"1274_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.17269\/s41997-018-0126-6","volume":"109","author":"SC Mema","year":"2018","unstructured":"Mema SC, Sage C, Xu Y, Tupper KW, Ziemianowicz D, McCrae K, Leigh M, Munn MB, Taylor D, Corneil T. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Can J Public Health. 2018;109:740\u20134.","journal-title":"Can J Public Health"},{"key":"1274_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1037\/pha0000452","volume":"29","author":"JJ Palamar","year":"2021","unstructured":"Palamar JJ, Fitzgerald ND, Keyes KM, Cottler LB. Drug checking at dance festivals: A review with recommendations to increase generalizability of findings. Exp Clin Psychopharmacol. 2021;29:229\u201335.","journal-title":"Exp Clin Psychopharmacol"},{"key":"1274_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/dar.12576","volume":"37","author":"MJ Barratt","year":"2018","unstructured":"Barratt MJ, Bruno R, Ezard N, Ritter A. Pill testing or drug checking in australia: acceptability of service design features. Drug Alcohol Rev. 2018;37:226\u201336.","journal-title":"Drug Alcohol Rev"},{"key":"1274_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.drugalcdep.2017.12.026","volume":"185","author":"MC Kennedy","year":"2018","unstructured":"Kennedy MC, Scheim A, Rachlis B, Mitra S, Bardwell G, Rourke S, Kerr T. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian City. Drug Alcohol Depend. 2018;185:248\u201352.","journal-title":"Drug Alcohol Depend"},{"key":"1274_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","volume":"68","author":"SG Sherman","year":"2019","unstructured":"Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three united States cities: baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46\u201353.","journal-title":"Int J Drug Policy"},{"key":"1274_CR19","doi-asserted-by":"publisher","first-page":"103781","DOI":"10.1016\/j.drugpo.2022.103781","volume":"107","author":"I Rammohan","year":"2022","unstructured":"Rammohan I, Bouck Z, Fusigboye S, Bowles J, McDonald K, Maghsoudi N, Scheim A, Werb D. Drug checking use and interest among people who inject drugs in toronto, Canada. Int J Drug Policy. 2022;107:103781.","journal-title":"Int J Drug Policy"},{"key":"1274_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-020-00373-4","volume":"17","author":"B Wallace","year":"2020","unstructured":"Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, Aasen J, Pauly B, Hore D. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17:29.","journal-title":"Harm Reduct J"},{"key":"1274_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.drugpo.2019.06.018","volume":"71","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, Boyd J, Tupper KW, Kerr T. We don\u2019t got that kind of time, man. We\u2019re trying to get high! Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs. Int J Drug Policy. 2019;71:125\u201332.","journal-title":"Int J Drug Policy"},{"key":"1274_CR22","unstructured":"Le N\u00e9zet O, Philippon A, Lahaie E, Andler R. Les niveaux d\u2019usage de cannabis en France en 2020. 2021;6."},{"key":"1274_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7517-8-16","volume":"8","author":"I Hungerbuehler","year":"2011","unstructured":"Hungerbuehler I, Buecheli A, Schaub M. Drug checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich\u2019s drug checking services. Harm Reduct J. 2011;8:16.","journal-title":"Harm Reduct J"},{"key":"1274_CR24","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.drugpo.2021.103293","volume":"95","author":"RPJ Koning","year":"2021","unstructured":"Koning RPJ, Benschop A, Wijffels C, Noijen J. Visitors of the Dutch drug checking services: profile and drug use experience. Int J Drug Policy. 2021;95:103293.","journal-title":"Int J Drug Policy"},{"key":"1274_CR25","unstructured":"Detrez V. Circulation d\u2019herbe de cannabis adult\u00e9r\u00e9e avec des cannabino\u00efdes de synth\u00e8se [Note SINTES]. 2020."},{"key":"1274_CR26","unstructured":"Boulat T, Cadet-Ta\u00efrou A, Gandilhon M, N\u00e9fau T, Lahaie E. (2016) Auto-culture d\u2019herbe de cannabis En france: cultivateurs et production \u00e0 Travers l\u2019enqu\u00eate SINTES cannabis 2013. Courr Addict 16\u20139."},{"key":"1274_CR27","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1017\/S0033291715001178","volume":"45","author":"TP Freeman","year":"2015","unstructured":"Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med. 2015;45:3181\u20139.","journal-title":"Psychol Med"},{"key":"1274_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163:1344\u201364.","journal-title":"Br J Pharmacol"},{"key":"1274_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","volume":"4","author":"M Colizzi","year":"2017","unstructured":"Colizzi M, Bhattacharyya S. Does Cannabis composition matter?? Differential effects of Delta-9-tetrahydrocannabinol and Cannabidiol on human cognition. Curr Addict Rep. 2017;4:62\u201374.","journal-title":"Curr Addict Rep"},{"key":"1274_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.forsciint.2017.01.007","volume":"272","author":"L Dujourdy","year":"2017","unstructured":"Dujourdy L, Besacier F. A study of cannabis potency in France over a 25 years period (1992\u20132016). Forensic Sci Int. 2017;272:72\u201380.","journal-title":"Forensic Sci Int"},{"key":"1274_CR31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/add.15253","volume":"116","author":"TP Freeman","year":"2021","unstructured":"Freeman TP, Craft S, Wilson J, Stylianou S, ElSohly M, Di Forti M, Lynskey MT. Changes in delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction. 2021;116:1000\u201310.","journal-title":"Addiction"},{"key":"1274_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/dta.3436","volume":"15","author":"N Fabresse","year":"2023","unstructured":"Fabresse N, Faltot M, Roux P, Becam J, Doudon E, Lacarelle B, Solas C, Pelissier-Alicot A-L. Determination of cannabinoids content in light cannabis inflorescences sold in France. Drug Test Anal. 2023;15:689\u201394.","journal-title":"Drug Test Anal"},{"key":"1274_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","volume":"144","author":"MS Castaneto","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12\u201341.","journal-title":"Drug Alcohol Depend"},{"key":"1274_CR34","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/bcp.13695","volume":"84","author":"LM Dryburgh","year":"2018","unstructured":"Dryburgh LM, Bolan NS, Grof CPL, Galettis P, Schneider J, Lucas CJ, Martin JH. Cannabis contaminants: sources, distribution, human toxicity and Pharmacologic effects. Br J Clin Pharmacol. 2018;84:2468\u201376.","journal-title":"Br J Clin Pharmacol"},{"key":"1274_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1360-0443.2008.02230.x","volume":"103","author":"J McLaren","year":"2008","unstructured":"McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction. 2008;103:1100\u20139.","journal-title":"Addiction"},{"key":"1274_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/can.2020.0092","volume":"7","author":"D Hammond","year":"2022","unstructured":"Hammond D, Goodman S. Knowledge of tetrahydrocannabinol and Cannabidiol levels among Cannabis consumers in the united States and Canada. Cannabis Cannabinoid Res. 2022;7:345\u201354.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1274_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/09687637.2020.1752150","volume":"28","author":"DJ Kruger","year":"2021","unstructured":"Kruger DJ, Kruger JS, Collins RL. Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages. Drugs Educ Prev Policy. 2021;28:97\u2013103.","journal-title":"Drugs Educ Prev Policy"},{"key":"1274_CR38","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/add.12634","volume":"109","author":"TP Freeman","year":"2014","unstructured":"Freeman TP, Morgan CJA, Hindocha C, Schafer G, Das RK, Curran HV. Just say \u2018know\u2019: how do cannabinoid concentrations influence users\u2019 estimates of cannabis potency and the amount they roll in joints? Addiction. 2014;109:1686\u201394.","journal-title":"Addiction"},{"key":"1274_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12954-020-00429-5","volume":"17","author":"S Shirley-Beavan","year":"2020","unstructured":"Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in barcelona, Spain. Harm Reduct J. 2020;17:78.","journal-title":"Harm Reduct J"},{"key":"1274_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/0038038514547896","volume":"49","author":"SL Dahl","year":"2015","unstructured":"Dahl SL, Sandberg S. Female Cannabis users and new masculinities: the gendering of Cannabis use. Sociology. 2015;49:696\u2013711.","journal-title":"Sociology"},{"key":"1274_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0011128708327955","volume":"57","author":"ML Griffin","year":"2011","unstructured":"Griffin ML, Rodriguez N. The gendered nature of drug acquisition behavior within marijuana and crack drug markets. Crime Delinquency. 2011;57:408\u201331.","journal-title":"Crime Delinquency"},{"key":"1274_CR42","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/ijerph17030947","volume":"17","author":"N Hemsing","year":"2020","unstructured":"Hemsing N, Greaves L. Gender norms, roles and relations and Cannabis-Use patterns: A scoping review. Int J Environ Res Public Health. 2020;17:947.","journal-title":"Int J Environ Res Public Health"},{"key":"1274_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2458-12-80","volume":"12","author":"K S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska Z, Brand H, (HLS-EU) Consortium Health Literacy Project European. Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health. 2012;12:80.","journal-title":"BMC Public Health"},{"key":"1274_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2018.11.001","volume":"67","author":"F Measham","year":"2019","unstructured":"Measham F. Drug safety testing, disposals and dealing in an english field: exploring the operational and behavioural outcomes of the uk\u2019s first onsite \u2018drug checking\u2019 service. Int J Drug Policy. 2019;67:102\u20137.","journal-title":"Int J Drug Policy"},{"key":"1274_CR45","first-page":"1","volume":"0","author":"M Bastien","year":"2023","unstructured":"Bastien M, Mezaache S, Donadille C, Martin V, Appel L, Lebrun M, Briand Madrid L, Barr\u00e9 T, Roux P. Exclusive therapeutic use of Cannabis in a large sample of daily Cannabis users in france: A Cross-Sectional survey. J Psychoact Drugs. 2023;0:1\u201311.","journal-title":"J Psychoact Drugs"},{"key":"1274_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/02791072.2015.1096433","volume":"47","author":"LA Osborn","year":"2015","unstructured":"Osborn LA, Lauritsen KJ, Cross N, Davis AK, Rosenberg H, Bonadio F, Lang B. Self-Medication of somatic and psychiatric conditions using botanical marijuana. J Psychoact Drugs. 2015;47:345\u201350.","journal-title":"J Psychoact Drugs"},{"key":"1274_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","volume":"24","author":"Z Walsh","year":"2013","unstructured":"Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24:511\u20136.","journal-title":"Int J Drug Policy"},{"key":"1274_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2017.05.046","volume":"47","author":"R Capler","year":"2017","unstructured":"Capler R, Walsh Z, Crosby K, Belle-Isle L, Holtzman S, Lucas P, Callaway R. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada. Int J Drug Policy. 2017;47:1\u20138.","journal-title":"Int J Drug Policy"},{"key":"1274_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1108\/DAT-06-2019-0021","volume":"19","author":"SR Sznitman","year":"2019","unstructured":"Sznitman SR, Barratt MJ, Decorte T, Hakkarainen P, Lenton S, Potter G, Werse B, Wilkins C. Do medical cannabis growers attempt to produce cannabis with different cannabinoid concentrations than recreational growers? Drugs Alcohol Today. 2019;19:251\u20136.","journal-title":"Drugs Alcohol Today"},{"key":"1274_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.drugpo.2009.11.002","volume":"21","author":"A Ritter","year":"2010","unstructured":"Ritter A. Illicit drugs policy through the lens of regulation. Int J Drug Policy. 2010;21:265\u201370.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01274-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01274-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01274-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:40:20Z","timestamp":1757263220000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01274-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01274-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"126"}}